Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Current Deferred Revenue (2023)

Historic Current Deferred Revenue for Abivax (ABVX) over the last 1 years, with Q4 2023 value amounting to $55948.9.

  • Abivax's Current Deferred Revenue changed N/A to $55948.9 in Q4 2023 from the same period last year, while for Dec 2023 it was $55948.9, marking a year-over-year change of. This contributed to the annual value of $56249.3 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Abivax's Current Deferred Revenue is $55948.9.
  • Abivax's 5-year Current Deferred Revenue high stood at $55948.9 for Q4 2023, and its period low was $55948.9 during Q4 2023.